Debating the Best Treatment for Early Prostate Cancer: Surgery, Radiation, or Neither - 2021 Annual Meeting
This course involves a case-based discussion with a panel of experts to review the various treatment options for early stage prostate cancer, including active surveillance, radical prostatectomy, external beam radiotherapy (including intensity modulated radiation therapy and stereotactic body radiation therapy), brachytherapy, and proton beam therapy. Each modality is discussed in the context of the impact on patient-centered quality of life.
This activity is available from March 1, 2022, through 11:59 p.m. Eastern time on February 28, 2025.
This activity was originally recorded at ASTRO’s 2021 Annual Meeting, October 24-27th.
The activity is designed to meet the interests of radiation oncologists, radiation oncology residents, surgeons, nurses, radiation therapists and medical oncologists.
Upon completion of this activity, participants should be able to:
- Discuss the various treatment options for early stage prostate cancer.
- Explain the impact of active surveillance versus active treatment on patient quality of life and tumor control.
- Identify barriers to adopting newer treatment strategies for early stage prostate cancer.
- Rahul D. Tendulkar, MD, Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic and receives compensation from Varian Medical Systems.
- Andrew J Stephenson, MBA, MD, Rush University Medical Center and receives compensation from Exact Sciences.
- Alison Tree, MBBS, MD, The Royal Marsden NHS Foundation Trust and and receives compensation from Electa, Accuray, Janssen and Varian Medical Systems.
- Karen E. Hoffman, MD is employed Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center and receives compensation from from Janssen and Varian Medical Systems.
- Gerard Morton, MD, Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, University of Toronto and has no financial relationships with a commercial interest.
The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
- 1.00 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.
Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.